Guidelines for use of diuretics: a view from a member of JNC 7.
作者信息
Carter Barry L
出版信息
J Clin Hypertens (Greenwich). 2012 May;14(5):273-6. doi: 10.1111/j.1751-7176.2012.00621.x. Epub 2012 Apr 11.
Abstract
摘要
相似文献
1
Guidelines for use of diuretics: a view from a member of JNC 7.利尿剂使用指南：美国国家高血压教育计划联合委员会第七次报告成员的观点
J Clin Hypertens (Greenwich). 2012 May;14(5):273-6. doi: 10.1111/j.1751-7176.2012.00621.x. Epub 2012 Apr 11.
2
Which diuretic is the preferred agent for treating essential hypertension: hydrochlorothiazide or chlorthalidone?治疗原发性高血压时，首选哪种利尿剂：氢氯噻嗪还是氯噻酮？
Curr Cardiol Rep. 2012 Dec;14(6):673-7. doi: 10.1007/s11886-012-0307-5.
3
Diuretics for hypertension: Hydrochlorothiazide or chlorthalidone?用于治疗高血压的利尿剂：氢氯噻嗪还是氯噻酮？
Cleve Clin J Med. 2015 Aug;82(8):527-33. doi: 10.3949/ccjm.82a.14091.
4
Are chlorthalidone and hydrochlorothiazide equivalent blood-pressure-lowering medications?氯噻酮和氢氯噻嗪是等效的降压药物吗？
J Clin Hypertens (Greenwich). 2005 Jun;7(6):354-6. doi: 10.1111/j.1524-6175.2005.04451.x.
5
Diuretic of choice in ABFM hypertension self-assessment module simulations.ABFM 高血压自我评估模块模拟中的首选利尿剂。
J Am Board Fam Med. 2012 Nov-Dec;25(6):805-9. doi: 10.3122/jabfm.2012.06.110343.
6
Evidence-based diuretics: focus on chlorthalidone and indapamide.循证利尿剂：聚焦氯噻酮和吲达帕胺
Future Cardiol. 2015 Mar;11(2):203-17. doi: 10.2217/fca.14.83.
7
Hydrochlorothiazide vs. chlorthalidone as the optimal diuretic for the management of hypertension.氢氯噻嗪与氯噻酮作为治疗高血压的最佳利尿剂。
Curr Pharm Des. 2013;19(21):3766-72. doi: 10.2174/13816128113199990315.
8
Chlorthalidone versus hydrochlorothiazide as the preferred diuretic: is there a verdict yet?氯噻酮与氢氯噻嗪作为首选利尿剂：已有定论了吗？
Hypertension. 2011 Apr;57(4):665-6. doi: 10.1161/HYPERTENSIONAHA.110.164566. Epub 2011 Mar 7.
9
Hydrochlorothiazide versus chlorthalidone: evidence supporting their interchangeability.氢氯噻嗪与氯噻酮：支持二者可互换使用的证据。
Hypertension. 2004 Jan;43(1):4-9. doi: 10.1161/01.HYP.0000103632.19915.0E. Epub 2003 Nov 24.
10
Chlorthalidone versus hydrochlorothiazide: a tale of tortoises and a hare.氯噻酮与氢氯噻嗪：龟兔赛跑的故事。
Hypertension. 2011 Dec;58(6):994-5. doi: 10.1161/HYPERTENSIONAHA.111.183525. Epub 2011 Oct 24.
引用本文的文献
1
Effect of the combination of bumetanide plus chlorthalidone on hypertension and volume overload in patients with chronic kidney disease stage 4-5 KDIGO without renal replacement therapy: a double-blind randomized HEBE-CKD trial.在未接受肾脏替代治疗的 4-5 期慢性肾脏病 KDIGO 患者中，布美他尼联合氯噻酮对高血压和容量超负荷的影响：一项双盲随机 HEBE-CKD 试验。
BMC Nephrol. 2022 Sep 20;23(1):316. doi: 10.1186/s12882-022-02930-4.
2
Diuretic and Anti-Inflammatory Activities of the Microencapsulated Acrocomia aculeata (Arecaceae) Oil on Wistar Rats.微囊化刺葵（棕榈科）油对Wistar大鼠的利尿和抗炎活性
J Med Food. 2015 Jun;18(6):656-62. doi: 10.1089/jmf.2014.0077. Epub 2014 Nov 4.
3
Which thiazide to choose as add-on therapy for hypertension?选择哪种噻嗪类药物作为高血压的附加治疗药物？
Integr Blood Press Control. 2014 Jul 30;7:35-47. doi: 10.2147/IBPC.S40248. eCollection 2014.
本文引用的文献
1
Why are we still using hydrochlorothiazide?我们为什么还在使用氢氯噻嗪？
J Clin Hypertens (Greenwich). 2011 Dec;13(12):867-9. doi: 10.1111/j.1751-7176.2011.00566.x. Epub 2011 Dec 1.
2
Chlorthalidone reduces cardiovascular events compared with hydrochlorothiazide: a retrospective cohort analysis.氯噻酮比氢氯噻嗪更能降低心血管事件：一项回顾性队列分析。
Hypertension. 2011 Apr;57(4):689-94. doi: 10.1161/HYPERTENSIONAHA.110.161505. Epub 2011 Mar 7.
3
Renewed interest in chlorthalidone: evidence from the Veterans Health Administration.对氯噻酮的重新关注：来自退伍军人健康管理局的证据。
J Clin Hypertens (Greenwich). 2010 Dec;12(12):927-34. doi: 10.1111/j.1751-7176.2010.00373.x. Epub 2010 Aug 30.
4
Diuretic therapy: key aspects in hypertension and renal disease.利尿剂治疗：高血压和肾脏疾病的关键方面。
J Nephrol. 2010 Sep-Oct;23(5):487-93.
5
Historical perspective of low- vs. high-dose diuretics.低剂量与高剂量利尿剂的历史视角。
J Am Soc Hypertens. 2007 Nov-Dec;1(6):373-80. doi: 10.1016/j.jash.2007.06.007.
6
Meta-analysis of dose-response characteristics of hydrochlorothiazide and chlorthalidone: effects on systolic blood pressure and potassium.氢氯噻嗪和氯噻酮剂量-反应特征的荟萃分析：对收缩压和钾的影响。
Am J Hypertens. 2010 Apr;23(4):440-6. doi: 10.1038/ajh.2010.1. Epub 2010 Jan 28.
7
Use of diuretics in patients with hypertension.利尿剂在高血压患者中的应用。
N Engl J Med. 2009 Nov 26;361(22):2153-64. doi: 10.1056/NEJMra0907219.
8
Impact of abdominal obesity on incidence of adverse metabolic effects associated with antihypertensive medications.腹型肥胖对与降压药物相关的不良代谢影响发生率的影响。
Hypertension. 2010 Jan;55(1):61-8. doi: 10.1161/HYPERTENSIONAHA.109.139592. Epub 2009 Nov 16.
9
Efficacy of spironolactone therapy in patients with true resistant hypertension.螺内酯治疗真性难治性高血压患者的疗效。
Hypertension. 2010 Jan;55(1):147-52. doi: 10.1161/HYPERTENSIONAHA.109.140988. Epub 2009 Oct 26.
10
Lack of correlation between thiazide-induced hyperglycemia and hypokalemia: subgroup analysis of results from the pharmacogenomic evaluation of antihypertensive responses (PEAR) study.噻嗪类药物所致高血糖与低钾血症之间缺乏相关性：降压反应药物基因组学评估（PEAR）研究结果的亚组分析
Pharmacotherapy. 2009 Oct;29(10):1157-65. doi: 10.1592/phco.29.10.1157.
Zotero 插件